DoD's $33.7M R&D Contract for Biotechnology Development Awarded to L3 Technologies Under Full and Open Competition

Contract Overview

Contract Amount: $33,720,844 ($33.7M)

Contractor: L3 Technologies, Inc.

Awarding Agency: Department of Defense

Start Date: 2020-12-18

End Date: 2025-09-18

Contract Duration: 1,735 days

Daily Burn Rate: $19.4K/day

Competition Type: FULL AND OPEN COMPETITION

Number of Offers Received: 2

Pricing Type: COST PLUS INCENTIVE FEE

Sector: R&D

Official Description: NGJ LB CB1 DEVELOPMENT

Place of Performance

Location: SALT LAKE CITY, SALT LAKE County, UTAH, 84116

State: Utah Government Spending

Plain-Language Summary

Department of Defense obligated $33.7 million to L3 TECHNOLOGIES, INC. for work described as: NGJ LB CB1 DEVELOPMENT Key points: 1. Contract awarded to L3 Technologies for $33.7M for R&D in Biotechnology. 2. Full and open competition was utilized, suggesting a competitive bidding process. 3. The contract duration is 1735 days, ending in September 2025. 4. Research and Development in Biotechnology (except Nanobiotechnology) is the focus area. 5. The contract type is Cost Plus Incentive Fee, common for R&D projects.

Value Assessment

Rating: good

The contract value of $33.7M for a 5-year R&D effort appears reasonable given the specialized nature of biotechnology research. Benchmarking against similar R&D contracts in this niche sector would provide a more precise assessment.

Cost Per Unit: N/A

Competition Analysis

Competition Level: full-and-open

The contract was awarded under full and open competition, indicating that multiple bidders were likely considered. This method generally promotes price discovery and can lead to more competitive pricing.

Taxpayer Impact: Taxpayer funds are being used for advanced research and development, which can lead to future technological advancements and economic benefits, though the immediate return on investment is uncertain.

Public Impact

Advancement in biotechnology research could lead to new medical treatments or industrial applications. Investment in R&D supports innovation and potentially creates high-skilled jobs. The specific outcomes and benefits of this research will become clearer as the project progresses. Competition in this sector can drive innovation and efficiency.

Waste & Efficiency Indicators

Waste Risk Score: 50 / 10

Warning Flags

  • Cost Plus Incentive Fee contracts can sometimes lead to cost overruns if not managed tightly.
  • The specific R&D outcomes are inherently uncertain, posing a risk to the return on investment.
  • Reliance on a single awardee for a significant R&D project.

Positive Signals

  • Awarded under full and open competition.
  • Focus on a critical R&D area (Biotechnology).
  • Long-term contract duration allows for sustained research effort.

Sector Analysis

This contract falls within the Research and Development in Biotechnology sector, a field characterized by high innovation, significant investment, and long development cycles. Spending benchmarks in this area are highly variable depending on the specific research focus.

Small Business Impact

The data indicates this contract was not set aside for small businesses and was awarded to L3 Technologies, Inc., a large corporation. There is no indication of small business participation in this specific award.

Oversight & Accountability

The Department of Defense, through the Defense Contract Management Agency, is responsible for overseeing this contract. Standard oversight mechanisms for R&D contracts, including progress reviews and financial audits, should be in place.

Related Government Programs

  • Research and Development in Biotechnology (except Nanobiotechnology)
  • Department of Defense Contracting
  • Defense Contract Management Agency Programs

Risk Flags

  • Potential for cost overruns in CPIF contracts.
  • Inherent uncertainty of R&D outcomes.
  • Lack of specific performance metrics in provided data.
  • No small business participation noted.

Tags

research-and-development-in-biotechnolog, department-of-defense, ut, definitive-contract, 10m-plus

Frequently Asked Questions

What is this federal contract paying for?

Department of Defense awarded $33.7 million to L3 TECHNOLOGIES, INC.. NGJ LB CB1 DEVELOPMENT

Who is the contractor on this award?

The obligated recipient is L3 TECHNOLOGIES, INC..

Which agency awarded this contract?

Awarding agency: Department of Defense (Defense Contract Management Agency).

What is the total obligated amount?

The obligated amount is $33.7 million.

What is the period of performance?

Start: 2020-12-18. End: 2025-09-18.

What are the specific research objectives and expected deliverables for this biotechnology development contract?

The specific research objectives and expected deliverables are not detailed in the provided data. However, given the NAICS code 541714 (Research and Development in Biotechnology), the contract likely aims to advance scientific knowledge or develop new biotechnological products, processes, or services. Further details would typically be found in the contract's statement of work.

How will the performance incentives in the Cost Plus Incentive Fee structure be measured and rewarded?

The performance incentives for a Cost Plus Incentive Fee (CPIF) contract are typically tied to achieving specific technical milestones, cost targets, or delivery schedules. The government and the contractor negotiate these metrics beforehand. If the contractor meets or exceeds these targets, they receive a higher profit margin than the base fee; conversely, failing to meet them results in a reduced profit.

What is the potential long-term impact of this R&D investment on national security or economic competitiveness?

Investments in biotechnology R&D can have significant long-term impacts. For national security, this could include advancements in medical countermeasures, biodefense, or novel materials. Economically, successful research can lead to new industries, job creation, and a competitive edge in a rapidly evolving global market. The specific impact depends heavily on the success of the research outcomes.

Industry Classification

NAICS: Professional, Scientific, and Technical ServicesScientific Research and Development ServicesResearch and Development in Biotechnology (except Nanobiotechnology)

Product/Service Code: RESEARCH AND DEVELOPMENTC – National Defense R&D Services

Competition & Pricing

Extent Competed: FULL AND OPEN COMPETITION

Solicitation Procedures: NEGOTIATED PROPOSAL/QUOTE

Solicitation ID: N0001919R0069

Offers Received: 2

Pricing Type: COST PLUS INCENTIVE FEE (V)

Evaluated Preference: NONE

Contractor Details

Address: 640 N 2200 W, SALT LAKE CITY, UT, 84116

Business Categories: Category Business, Corporate Entity Not Tax Exempt, Manufacturer of Goods, Not Designated a Small Business, Special Designations, U.S.-Owned Business

Financial Breakdown

Contract Ceiling: $495,530,542

Exercised Options: $495,530,542

Current Obligation: $33,720,844

Subaward Activity

Number of Subawards: 8

Total Subaward Amount: $771,323

Contract Characteristics

Commercial Item: COMMERCIAL PRODUCTS/SERVICES PROCEDURES NOT USED

Cost or Pricing Data: NO

Timeline

Start Date: 2020-12-18

Current End Date: 2025-09-18

Potential End Date: 2025-09-30 00:00:00

Last Modified: 2025-09-24

More Contracts from L3 Technologies, Inc.

View all L3 Technologies, Inc. federal contracts →

Other Department of Defense Contracts

View all Department of Defense contracts →

Explore Related Government Spending